Christopher Amos, M.D., Ph.D.
Baylor College of Medicine
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR170048|
Recruitment of Established Investigators
Dartmouth - Geisel School of Medicine
August 16, 2017
Lung cancer is by far the most deadly of all cancers, killing more than 150,000 men and women in the U.S. annually. Not everyone diagnosed with lung cancer dies of the disease, but if the cancer returns after initially successful treatment, it is usually aggressive and deadly.
Now a scientist who studies factors that contribute to the recurrence of early-stage lung cancers has been recruited to Baylor College of Medicine. Christopher Amos became director for the Institute of Clinical and Translational Research with the help of a Recruitment of Established Investigators Award from CPRIT in 2017. He was chair of the Department of Biomedical Data Science at Geisel, and returns to Texas, where he was on the faculty at MD Anderson for 19 years.